US Patent 8399508 Olopatadine formulations for topical nasal administration
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+203 characters)
Article
Patent abstract
Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the nose are disclosed. The aqueous formulations contain approximately 0.6% (w/v) of olopatadine.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
G. Michael Wall0
Masood A. Chowhan0
Onkar N. Singh0
Rajni Jani0
Wesley Wehsin Han0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08399508 Olopatadine formulations for topical nasal administration US Patent 8399508 Olopatadine formulations for topical nasal administration
Infobox
Patent Number
083995080
Patent Number
83995080
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
083995080
Date of Patent
March 19, 2013
0Patent Application Number
131736080
Date Filed
June 30, 2011
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08399508 Olopatadine formulations for topical nasal administration
Infobox
Is a
Patent jurisdiction
Patent number
08399508
Date of patent
March 19, 2013
Patent application number
13173608
Date Filed
June 30, 2011
Patent primary examiner
Find more entities like US Patent 8399508 Olopatadine formulations for topical nasal administration
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.